Cite
MLA Citation
R. Reggia et al.. “SAT0205 Failure of the Switch from the Intravenous to the Subcutaneous Formulation of Abatacept due to a Disease Reactivation: Our Experience.” Annals of the rheumatic diseases, vol. 74, n.d., p. 731. http://access.bl.uk/ark:/81055/vdc_100135161825.0x000057